Oncology
Showing of 52 results
Cholesterol Drug Repurposed as Investigational Therapy for HPV+ Cancers at University Hospitals Seidman Cancer Center in Nation’s First-Ever Clinical Trials
UH Seidman Cancer Center will soon begin to look into the use of fenofibrate as a potential treatment for HPV+ cancers.
University Hospitals to Invest $39 Million to Build Regional Cancer Hub at UH TriPoint Medical Center
Regional hub will help better serve patients east of Cleveland; Oncology services will also be expanded at UH Minoff Health Center in Beachwood.
University Hospitals Seidman Cancer Center is one of the first in North America to offer Varian Ethos 2.0 for cancer patients
The radiation treatment allows for unprecedented targeting of tumors while sparing healthy organs in almost a dozen different types of cancer.
UH Seidman Cancer Center Offers Patients Rare Access to New Kidney Cancer Tracer
UH Seidman Cancer Center is one of just a few cancer centers nationwide to offer its patients early access to a novel and more sensitive method of diagnosing kidney cancer.
International Leader in Cancer Research at University Hospitals Seidman Cancer Center Passes Away
Nathan Berger, MD, Ph.D was Chief of the Hematology and Oncology Division of University Hospitals.
UH Seidman Cancer Center Researchers Awarded ASCO Young Investigator Awards
James Ignatz-Hoover, MD, PhD and Courtney Pisano, DO, MS, MPH will each receive $50,000 research funding from The American Society of Clinical Oncology for their respective research projects in clinical oncology.
UH First Health System in Northeast Ohio to Widely Offer Galleri®, a Multi-cancer Early Detection Blood Test Designed to Screen for More Than 50 Types of Cancer
UH planning multiple screening events with first responders throughout region – including the first with the city of Highland Heights.
Novel Oral Hormone Therapy Shows Promising Results for Prostate Cancer Treatment with Radiation Therapy
A high impact study led by Daniel Spratt, MD, demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer.